NCT02586207 2025-10-07Pembrolizumab in Combination With CRT for LA-SCCHNSanford HealthPhase 1 Completed59 enrolled 9 charts
NCT06056310 2025-09-29Phase 1b Safety Study of Xevinapant, Weekly Cisplatin, and RT in Participants With Unresected LA SCCHN (HyperlynX)EMD SeronoPhase 1 Terminated18 enrolled 9 charts